SYED HASAN: Open Payments
NPI 1619909991 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 4 payments from 3 companies in 2025. Trend: 2023 $274 · 2024 $361 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
| ACADIA Pharmaceuticals Inc | 2 | $110 |
Products named: UZEDY, INGREZZA, NUPLAZID.
Industry payments across IN — which companies pay providers there.
